New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:04 EDTPBCT, BJRI, STRA, SINA, SSNI, STM, FUEL, RMD, QRE, NUS, NMM, MAIN, CLC, COLM, BBYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Best Buy (BBY) downgraded to Neutral from Buy at UBS... Clarcor (CLC) downgraded to Neutral from Outperform at RW Baird... Columbia Sportswear (COLM) downgraded to Neutral from Neutral at Macquarie... Main Street (MAIN) downgraded to Market Perform from Outperform at Raymond James... Navios Maritime Partners (NMM) downgraded to Hold from Buy at Stifel... Nu Skin (NUS) downgraded to Neutral from Buy at BofA/Merrill... QR Energy (QRE) downgraded to Hold from Buy at MLV & Co.... ResMed (RMD) downgraded to Neutral from Outperform at Macquarie... Rocket Fuel (FUEL) downgraded to Market Perform from Outperform at BMO Capital... STMicroelectronics (STM) downgraded to Neutral from Outperform at Exane BNP Paribas... Silver Spring Network (SSNI) downgraded to Neutral from Outperform at RW Baird... Strayer (STRA) downgraded to Underperform from Neutral at BofA/Merrill... SINA (SINA) downgraded to Hold from Buy at Jefferies... BJ's Restaurants (BJRI) downgraded to Neutral from Buy at Sterne Agee... People's United (PBCT) downgraded to Neutral from Overweight at JPMorgan.
News For BBY;COLM;CLC;MAIN;NMM;NUS;QRE;RMD;FUEL;STM;SSNI;SINA;STRA;BJRI;PBCT From The Last 14 Days
Check below for free stories on BBY;COLM;CLC;MAIN;NMM;NUS;QRE;RMD;FUEL;STM;SSNI;SINA;STRA;BJRI;PBCT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
05:16 EDTSTMSTMicroelectronics sees Q3 revenue up about 3%
Subscribe for More Information
05:12 EDTSTMSTMicroelectronics reports Q2 adjusted EPS 11c, consensus 3c
Subscribe for More Information
July 22, 2014
14:28 EDTNUSSam Antar cautious on Nu Skin in White Collar Fraud blog
Reference Link
July 21, 2014
14:32 EDTNUSNu Skin July weekly volatility increase on wide price movement
Subscribe for More Information
10:49 EDTSINABaidu advances following Morgan Stanley upgrade
Subscribe for More Information
10:45 EDTBBYAnalysts roll out coverage on GoPro with differing views
Shares of GoPro (GPRO) are climbing after a number of analysts initiated coverage of the stock with different outlooks. GoPro develops mountable and wearable cameras. BULLISH TAKE: JPMorgan analyst Paul Coster initiated coverage of GoPro with an Overweight rating. GoPro is gaining share in the digital camcorder market, and it has begun to penetrate "active lifestyle" markets, which are a much larger opportunity for the company, Coster believes. The company could ship 10M of its products for use by active lifestyle participants annually, the analyst estimated. In a best case scenario, the company could also sell low-cost devices for the mass market, according to Coster. However, GoPro will face competition from major companies, including Google (GOOG) and possibly Apple (AAPL) in this market, warned Coster, who set a $51 price target on GoPro. Also initiating coverage of the name with an Overweight rating was Piper Jaffray analyst Sean Naughton. GoPro is in the early stages of growth, as the company's user base is poised to expand beyond extreme sports enthusiasts, the analyst forecast. The company has a competitive advantage over other brands, which should enable it to maintain strong profitability, added Naughton, who set a $48 price target on the shares. BEARISH TAKE: Stifel analyst Jim Duffy started coverage of GoPro with a Hold rating. The company's three year growth outlook is compelling, but the stock is fully valued, the analyst believes. The company faces a number of risks, including competition in the image device market and the possibility that its relationship with key channel partners, including Best Buy (BBY), could be disrupted, the analyst wrote. Sales to Best Buy accounted for 17% of GoPro's revenue in fiscal 2013, Duffy reported. After GoPro surged following its initial public offering, the stock is likely to advance by only limited amounts, wrote Barcalys analyst Joseph Wolf, who initiated coverage of the shares with an Equal Weight rating. The stock could fall to $30 if the company is unable to increase its hardware sales or make progress in its efforts to develop a media business, the analyst warned. He set a $45 price target on the shares. PRICE ACTION: A total of seven analysts rolled out coverage today on GoPro, according to The Fly’s research, with only two recommending the stock with buy-equivalent ratings. Shares of the camera marker are up 3%, or $1.10, to $42.53 in morning trading.
08:15 EDTRMDITC rules redesigned APEX humidifier infringes ResMed patents
An ITC ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues to infringe ResMed patents in its humidification. The original ITC action filed by ResMed in March 2013 asserted patent infringement by four products: APEX iCH and XT Fit CPAP humidifiers, the WiZARD 220 full face mask, and the WiZARD 210 nasal mask. In July 2013, APEX agreed to entry of an order prohibiting it from infringing ResMed's patents. And as a result, APEX has been banned from selling infringing products in the United States. APEX then redesigned its products and sought a ruling that it had avoided ResMed's patents. In this new ruling, the full commission held that the APEX iCH humidifier continues to infringe. As a result, APEX should continue to be banned from selling the iCH humidifier in the United States. The redesigned APEX XT Fit was found not to infringe. But APEX's expert stated that the redesigned humidifiers compromised on functionality and performance. The redesigned WiZARD 220 full face mask – which now has a fused elbow instead of the more desirable detachable elbow -- was found not to infringe on ResMed patents. Again, APEX's expert noted that the redesigned masks sacrificed functional advantages present in the ResMed products. Finally, APEX chose to withdraw its redesigned WiZARD 210 nasal mask from these proceedings, so the July 2013 order remains in place as to that product.
July 18, 2014
10:03 EDTNUSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:24 EDTNUSOn The Fly: Pre-market Movers
Subscribe for More Information
08:28 EDTPBCTPeople's United announces formation of joint venture with Vantiv
Subscribe for More Information
08:28 EDTPBCTPeople's United reports Q2 operating EPS 20c, consensus 21c
Subscribe for More Information
06:52 EDTNUSNu Skin downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
July 17, 2014
10:00 EDTCLCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:23 EDTCLCClarcor upgraded to Outperform from Neutral at RW Baird
Baird upgraded Clacor (CLC) to Outperform citing improved core fundamentals, valuation and recent acquisition opportunities. Price target is $67.
July 16, 2014
12:22 EDTBBYBest Buy calls active on speculation of an activist investor stake
Subscribe for More Information
10:24 EDTBBYRumor: Best Buy moves up on speculation of an activist investor stake
Subscribe for More Information
06:49 EDTNUSNu Skin removed from short-term buy list at Deutsche Bank
Subscribe for More Information
July 15, 2014
14:59 EDTSTMSynaptics shares should be bought on weakness, says Cowen
Subscribe for More Information
09:59 EDTSTRAApollo Education discloses new Department of Education review
Subscribe for More Information
06:00 EDTSINAStocks with implied volatility movement; KGC SINA
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use